| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.0046 | 1 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.012 | 1 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.0045 | 1 |